Chemical differentiating agents. Differentiation of HL-60 cells by hexamethylenebis[acetamide]analogs
作者:Alberto Haces、Theodore R. Breitman、John S. Driscoll
DOI:10.1021/jm00385a025
日期:1987.2
Hexamethylenebis[acetamide] (HMBA) is an agent in clinical trial that induces differentiation of certain types of tumor cells to nonmalignant phenotypes. In an attempt to discover a more potent compound, a number of bis-functionalized amides, imides, and hydrazine derivatives of HMBA were prepared and evaluated in vitro with the HL-60 human promyelocytic leukemia cell line. Among the compounds evaluated, the 5,5-dimethylhydantoin derivative is almost 10 times more potent than HMBA in inducing differentiation. The bis-imide, diacetyl-HMBA, is both more potent and effective than its parent compound. Six of the 16 compounds evaluated cause at least 20% differentiation. An inverse relationship between the degree of differentiation and the percentage of viable cells is described for HMBA and its analogues.
HACES A.; BREITMAN T. R.; DRISCOLL J. S., J. MED. CHEM., 30,(1987) N 2, 405-409
作者:HACES A.、 BREITMAN T. R.、 DRISCOLL J. S.
DOI:——
日期:——
Poupaert, Jacques H.; Mergen, Frank; Lerot, Therese, Bulletin des Societes Chimiques Belges, 1988, vol. 97, # 6, p. 469 - 470
作者:Poupaert, Jacques H.、Mergen, Frank、Lerot, Therese